Craft

Sinphar Pharmaceutical

Stock Price

NT$30.8

2024-10-29

Market Capitalization

NT$5.6 B

2024-10-29

Revenue

NT$3.2 B

FY, 2024

Sinphar Pharmaceutical Summary

Company Summary

Overview
Sinphar Pharmaceutical (杏輝藥品工業股份有限公司) is a company that produces and markets therapeutic drugs, healthcare foods, and medical beauty products. It offers injections, tablets, capsules, plant extracts, moisturizers, and other products.
Type
Public
Status
Active
Founded
1977
Website
http://www.sinphar.com
Cybersecurity rating
Sectors

Table of Contents

Sinphar Pharmaceutical Financials

Summary Financials

Revenue (Q3, 2025)
NT$872.7M
Gross profit (Q3, 2025)
NT$447.0M
Net income (Q3, 2025)
NT$80.7M
Cash (Q3, 2025)
NT$895.2M
EBIT (Q3, 2025)
NT$108.7M
Enterprise value
$6.2B

Footer menu